Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
EU solidarity with Ukraine
Prozorro+: Ukrainian public procurement platform
Spain-Saragossa: Research and experimental development services
Prior information notice
This notice is for prior information only
Section I: Contracting authority
This PCP is carried out by Instituto Aragonés de Ciencias de la Salud, lead procurer acting in the name and on behalf of the buyers group in I.1). The applicable national procurement law is Spanish.
Section II: Object
Pre-commercial Public Procurement of Comprehensive Services to Patients in Need of Tele-rehabilitation in Isolated Areas, enhanced by Edge Technology, New Care Pathways and Community Support (ROSIA)
This PIN announces an open market consultation and provides information about a planned pre-commercial procurement (PCP) carried out by the ROSIA PCP project, addressing the rising need of comprehensive services, enhanced by edge technology, to patients in need of tele-rehabilitation in depopulated and distant areas. ROSIA PCP is looking to procure the development of an all in one service supported in an open platform which will integrate ICT enabled services including telerehabilitation and monitoring devices for self-care, implementation of new care pathways fostering community support, and resources for enabling patient activation.
More information about the upcoming open market consultation is provided in section II.2.14).
The contract will be executed at the institution of each member.
The procurement will take the form of a joint pre-commercial procurement (PCP). The objective is to conduct a competitive multiple‐sourcing procedure for procuring research and development services to face a joint technologically demanding mid to long‐term challenge. The competitive process will be executed in three phases where different suppliers will compete to develop their solution in a narrowed down R&D framework of service contracts. The 3 phases are: solution design, prototype development, original development and validation and testing of a limited volume of first products or services. All the solutions in Phase 3 will be tested in the three buyers’ countries (Ireland, Portugal and Spain) to ensure that a comparison can be made of performance, both across sites and across solutions. Each procurer will identify a sample population to implement the proof of concept of the final awarded solutions.
Each selected operator will be awarded a framework agreement that covers three R&D phases. After each phase, intermediate evaluations will be carried out to select the best of the competing solutions. The contractors with the best value- for-money solutions will be offered a specific contract for the next phase. Contracts will include provisions on risk benefit sharing under market conditions, and a clear separation with the subsequent (possible) Public Procurements of Innovative solutions (PPI) focusing on deployment of commercial volumes of end‐products.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions.
This PIN invites all interested operators (regardless of their geographic location, the size or governance structure) to take part in an open market consultation (OMC).
The OMC will consist of:
— online events: one per procurers’ country (Ireland, Portugal and Spain) and another international one will be organized during the OMC. All meetings will be announced on the website (https://ROSIA-pcp.eu/),
— a questionnaire made available at Rosia´s web (https://ROSIA-pcp.eu/). The confidentiality terms applied to the information provided by the respondents during the OMC will be detailed at the questionnaire,
— individual meetings with respondents to the questionnaire. The meetings and phone calls schedule will be set up by the procurers according to interest and availability.
Interested operators can participate in the PCP call for tender even if they did not participate in the OMC. Participation in the OMC will not be a requirement to submit a proposal to the tender, does not lead to any rights or privileges for the participants, and is not part of any pre-qualification or selection process.
This procurement receives funding from the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No 101017606 — ROSIA PCP (https://ROSIA-pcp.eu/). The EU has given a grant for this procurement, but is not participating as a contracting authority in the procurement.
Estimated total value: EUR 3 900 000 incl. VAT, if applicable.
The procurement is expected to be published in March 2022, to start in September 2022 and to end in May 2025.
OMC will be held from June to August 2021.
All information provided during the OMC will be published, at least, in English.
Section IV: Procedure
Section VI: Complementary information
The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them (because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs). This PIN is published to announce an open market consultation on a future procurement procedure. The PIN is not a commitment to procure.